Company News

Revenue rose 31.1% to RMB 632 million, while net profit increased 47.8% to RMB 179 millionHANGZHOU, China, August 20, 2026 — Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, "Zylox-Tonb...

Zylox-Tonbridge’s first residential summer camp for employees’ children combined sports, educational visits, and group living in a six-day program to foster independence, curiosity, and teamwork. Th...

HANGZHOU, China, June 8, 2026 -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190; "Zylox-Tonbridge" or the "Company"), a Hong Kong-listed medical technology company focuse...

Hong Kong, January 29, 2026 — Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, the "Company" or "Zylox-Tonbridge") today announced a positive profit alert for the fiscal ...

Marks a major milestone in Zylox-Tonbridge's long-term commitment to global expansionBuilds an integrated global commercialization platform to accelerate Zylox-Tonbridge's adoption of innovati...

Zhuhai, China — January 11, 2026 — Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190), a leading innovator in neurovascular and peripheral vascular interventional solutions, hosted its Invest...